Clinical Perspectives

Personalized Breast Cancer Immunotherapy Trials

In the evolving landscape of breast cancer treatment, two groundbreaking clinical trials at Moffitt are offering new hope to patients with aggressive...

Expanding Treatment Horizons: Moffitt's Approach to Stage IV Esophageal Cancer Surgery

Historically, surgery has been considered inappropriate for patients with stage IV esophageal cancer, but Moffitt's experts suggested that...

Improving Survival Rates in Esophageal Cancer: Why Early Referral Matters

Early referral to Moffitt provides esophageal cancer patients access to world-class GI cancer expertise.

Expanding Minimally Invasive Options for Lung Metastases: The Role of Thermal Ablation

Moffitt Cancer Center has been working to expand access to thermal ablation for appropriate patients in the Southeast.

6 Common Bone Marrow Transplant Misconceptions for Leukemia Patients

If you have a patient with leukemia or hematologic malignancy, but you are unsure if they are eligible for bone marrow transplant, we encourage you...

The Power of Investigator-Initiated Trials

Discover how physician-led clinical trials at Moffitt are driving cancer breakthroughs and giving more patients access to promising new therapies.

Specialized Clinic for Bone Lesions and Bone Metastasis

The Sarcoma Program at Moffitt Cancer Center recently unveiled a new Bone Metastasis Clinic, a first of its kind in Florida and among only a handful...

Understanding MGUS: Why Early Monitoring Can Be Life-Changing

Mal Heme, Malignant Hematology, high-risk, patients Monoclonal Gammopathy of Undetermined Significance (MGUS)

From Clinical Trial to Standard of Care: Pembrolizumab Plus Chemoradiotherapy Available at Moffitt

The introduction of immunotherapy into the curative-intent setting has prompted a meaningful shift in cervical cancer treatment.

Now Enrolling: Novel Dendritic Cell Vaccines Immunotherapy Trial For HER2+ Breast Cancer

Dendritic cell vaccines study offers hope for a less toxic, more personalized approach for the treatment of HER2 breast cancer with less chemotherapy...

One of Only Five Multidisciplinary Cutaneous Lymphoma Clinics in U.S. is at Moffitt

Cutaneous lymphomas are a heterogenous group of lymphoproliferative disorders that present in the skin and are composed of malignant clonal T- or...

Q&A: Understanding Intralesional and Infusional Therapies for Metastatic Melanoma

Dr. Matthew Perez discusses intralesional and infusional therapies for metastatic melanoma.

Anaplastic Thyroid Cancer: A Rare but Urgent Diagnosis – What Referring Providers Need to Know

Recognizing, diagnosing and directing patients with suspected anaplastic thyroid cancer to multidisciplinary teams for timely and effective...

Dendritic Cell Vaccine Offers Hope for HER2-Positive Breast Cancer

NATASHA explores the efficacy of preoperative intratumoral dendritic cell vaccines combined with a de-escalated chemotherapy regimen, minimizing...

Guide on When to Refer Patients to the Endocrine Oncology Clinic at Moffitt

Moffitt's Endocrine Oncology Program offers a multidisciplinary approach to managing both common and rare endocrine tumors.